Antibody trials sponsored by Regeneron and Eli Lilly are off to a slow start because of a dearth of tests, overwhelmed hospitals and reluctant patients.
Coronavirus Antibody: Clinical Trials of Drugs Are Taking Longer Than Expected – The New York Times
The COVID-19 pandemic continues unabated and not impressed by the Kusher-Trump-Barr triumvirate.
Leave a Reply